EPIC Enzymes Pharmaceuticals & Industrial Chemicals Ltd. - Research Center
524374 EPICENZY Group (XT) BSE data
Results
Statement
More
Mar ' 12 |
Mar ' 11 |
Mar ' 10 |
Mar ' 09 |
Mar ' 08 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
-27.93 |
-27.70 |
-14.38 |
-12.99 |
6.30 |
Secured loans
14.74 |
14.74 |
14.55 |
14.55 |
14.56 |
Unsecured loans
Total
3.27 |
3.21 |
16.33 |
17.49 |
37.38 |
Gross block
1.97 |
1.98 |
28.24 |
28.24 |
28.27 |
Less : revaluation reserve
Less : accumulated depreciation
0.63 |
0.58 |
13.46 |
13.05 |
12.65 |
Net block
1.02 |
1.08 |
14.45 |
15.19 |
15.62 |
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
Miscellaneous expenses not written
Total
3.27 |
3.21 |
16.33 |
17.49 |
37.38 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
85.88 |
85.88 |
85.88 |
85.88 |
85.88 |